Frontlight ResearchEarly access
CompletedNo phase
Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1
Key facts
- Who runs it
- Oslo University Hospital
- Where
- Norway3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 89 people enrolled
- Started
- 10 Dec 2021
- Ended
- 31 Aug 2024
- Type of study
- Observational
- Record updated
- 27 April 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Genetically confirmed Myotonic Dystrophy type 1
Who cannot take part
- Unable to answer or understand questionnaires due to language barriers or cognitive status
- Unable to perform functional tests
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Myotonic Dystrophy type 1 (DM1) is a multisystem disease that causes muscle weakness and myotonia. As a result upper limb function might become impaired. In this study we will examine patients with DM1 and record their upper limb function. We will will use a battery of patient reported outcomes (PROs) and Outcome measures (OMs) in order to evalute which ones are suitable for use in clinical practise and research studies.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 27 April 2025